<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02577978</url>
  </required_header>
  <id_info>
    <org_study_id>STU00090745</org_study_id>
    <nct_id>NCT02577978</nct_id>
  </id_info>
  <brief_title>Stability of the Medial Pivot Total Knee Prosthesis</brief_title>
  <official_title>Stability of the Medial Pivot Total Knee Prosthesis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Northwestern University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Northwestern University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare objective and subjective measures of knee stability
      following total knee arthroplasty with a medial pivot design vs. a posterior stabilized
      design.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Several different prostheses are available for use in total knee arthroplasty (TKA). These
      designs aim to replicate the normal kinematics of the knee joint while maintaining stability
      throughout a full range of motion. The posterior cruciate ligament (PCL) contributes to these
      functions in the native knee, and if preserved it can function similarly in the prosthetic
      knee. Prostheses in which the PCL is sacrificed, and its function not replaced by other
      means, have poorer outcomes. However, various problems with preserving the PCL, including PCL
      deterioration in arthritic knees and difficulties with proper tensioning, have led to the
      development of alternative ways to emulate normal femoral rollback and sagittal plane
      stability. These posterior-substituted (PS) designs substitute for the PCL with either a cam
      and post mechanism or a symmetrical ultra-congruent tibial insert.

      The cruciate-retaining (CR) and PS designs, together with advances in surgical techniques and
      component materials, have achieved excellent implant survivorship with rates of &gt; 90% at 20
      years. Reports of functional outcomes, however, have been variable. One potential area for
      improvement in TKA is optimization of implant design to better approximate native knee
      kinematics. In the normal knee, the medial condyle remains stable in the sagittal plane,
      functioning like a ball-and-socket, whereas the lateral condyle translates anterior to
      posterior during flexion. The designs of the CR and PS knees do not allow for this
      medial-centered rotation. Analysis has revealed paradoxical anterior sliding of the femur
      during flexion, abnormal axial rotation, and condylar lift-off. Edge loading and increased
      sagittal plane motion may predispose to accelerated polyethylene wear. The posterior
      stabilized design uses a cam-and-post mechanism in which one piece of the prosthesis has a
      plastic post that fits into a slot in the other piece of the prosthesis.

      A newer design that attempts to address these issues is the medial pivot knee (MP). This
      design is characterized by an asymmetrical tibial insert in which the medial compartment is
      ultra-congruent, providing antero-posterior stability and the lateral compartment allows for
      rollback around a medial axis of rotation i.e uses a ball-and-socket mechanism. This design
      more accurately recreates normal knee kinematics, reduces anteroposterior instability, and
      avoids condylar lift-off. Early studies indicate improved polyethylene wear characteristics.
      Midterm studies report excellent implant survivorship and clinical outcomes.

      Several randomized trials have compared the MP knee favorably with other designs. Patients
      with bilateral TKAs with a different prosthesis on each side preferred their medial pivot
      knee to a PS, CR, or mobile-bearing (MB) design. A trial comparing the MP and PS designs
      found greater range of motion (ROM) and better patient-reported outcomes in the MP group at 2
      years. There also exists literature reporting poorer outcomes with the MP design. A trial
      involving 96 patients who had received both an MP knee and an MB knee on contralateral sides
      found lower ROM, higher complication rates, and worse patient reported outcomes in the MP
      knee.

      Given the lack of consensus in the literature, further investigation is warranted to
      determine the impact of the MP design on outcomes following TKA.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 2014</start_date>
  <completion_date type="Actual">June 2017</completion_date>
  <primary_completion_date type="Actual">April 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Oxford Knee Score (OKS) Pre-operative Through 2 Years Post-operative</measure>
    <time_frame>Pre-operatively on day of surgery, 6 weeks, 3 months, 6 months, 12 months and 24 months post-operatively</time_frame>
    <description>Patient completed Oxford Knee Score questionnaire used to assess the patient's perspective of outcome following Total Knee Arthroplasty (TKA); score range is reported between 0-48 with improvement in outcomes reflected as a higher numerical value (e.g. a 'complete' return to pre-disease functionality would be reported as a score of 48)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Veteran's RAND 12 (VR-12) Mental Composite Score (MCS) Through 2 Years Post Operative</measure>
    <time_frame>Pre-operatively, 6 weeks post-operatively, 3 months post-operatively, 6 months post-operatively, 12 months post-operatively, and 2 years post-operatively.</time_frame>
    <description>Veteran's RAND 12 Item Health Survey used to assess health-related quality of life, to estimate disease burden, and to evaluate disease-specific benchmarks. Scores for the Mental Composite Score (MCS) range from 5.2 to 76.3 and are evaluated as a summative T-score with population mean of 50 (Standard Deviation = 10);higher scores indicate improved mental wellness/function as reported by patients.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Veteran's RAND 12 (VR-12) Physical Composite Score (PCS) Through 2 Years Post Operative</measure>
    <time_frame>Pre-operatively, 6 weeks post-operatively, 3 months post-operatively, 6 months post-operatively, 12 months post-operatively, and 2 years post-operatively.</time_frame>
    <description>Veteran's RAND 12 Item Health Survey used to assess health-related quality of life, to estimate disease burden, and to evaluate disease-specific benchmarks. Scores for the Physical Composite Score (MCS) range from 6.3 to 71.8 and are evaluated as a summative T-score with population mean of 50 (Standard Deviation = 10);higher scores indicate improved physical wellness/function as reported by patients.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>PROMIS Computerized Adaptive Tests (CATs) for Physical Function Through 2 Years Post-operative</measure>
    <time_frame>Pre-operatively, 6 weeks post-operatively, 3 months post-operatively, 6 months post-operatively, 12 months post-operatively, and 2 years post-operatively.</time_frame>
    <description>Patient-reported outcome (PRO) measures use answers that patients provide to questions to produce numeric values which indicate patients' state of wellbeing or suffering as well as their ability or lack of ability to function. Values are reported as T-scores with a reference population mean of 50 (SD=10); for the Physical Function domain higher scores indicated improved physical function as reported by the patient</description>
  </primary_outcome>
  <primary_outcome>
    <measure>PROMIS Computerized Adaptive Tests (CATs) for Pain Interference Through 2 Years Post-operative</measure>
    <time_frame>Pre-operatively, 6 weeks post-operatively, 3 months post-operatively, 6 months post-operatively, 12 months post-operatively, and 2 years post-operatively.</time_frame>
    <description>Patient-reported outcome (PRO) measures use answers that patients provide to questions to produce numeric values which indicate patients' state of wellbeing or suffering as well as their ability or lack of ability to function. Values are reported as T-scores with a reference population mean of 50 (SD=10); for the Pain Interference domain an increased value indicates greater severity/frequency of pain reported by the patient.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>PROMIS Computerized Adaptive Tests (CATs) for Pain Behavior Through 2 Years Post-operative</measure>
    <time_frame>Pre-operatively, 6 weeks post-operatively, 3 months post-operatively, 6 months post-operatively, 12 months post-operatively, and 2 years post-operatively.</time_frame>
    <description>Patient-reported outcome (PRO) measures use answers that patients provide to questions to produce numeric values which indicate patients' state of wellbeing or suffering as well as their ability or lack of ability to function. Values are reported as T-scores with a reference population mean of 50 (SD=10); for the Pain Behavior domain an increased value indicates greater severity/frequency of pain reported by the patient</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Total Score Calculated Using the Forgotten Joint Score in Order to Assess the Subject's Ability to Forget the Artificial Joint in Everyday Life</measure>
    <time_frame>12 months post-operatively</time_frame>
    <description>Patient completed questionnaire used to assess the patients' ability to forget about a joint as a result of successful treatment. Every question is scored 1 (never) to 5 (mostly) according to the selected response categories. Thus, the raw score ranges from 12 to 60 where a high score indicates an improved outcome. The raw score is linearly transformed to a 0-100 scale and then reversed to obtain the final score with higher scores indicating improved physical function/reduced impact of symptoms on activity:
Final score = 100 - ((sum(item01 to item12) - 12)/48*100)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>International Knee Documentation Committee (IKDC) Questionnaire Assessed Through 2 Years Post-op</measure>
    <time_frame>Pre-operatively, 6 weeks post-operatively, 3 months post-operatively, 6 months post-operatively, 12 months post-operatively, and 2 years post-operatively.</time_frame>
    <description>The International Knee Documentation Committe (IKDC) Questionnaire is a subjective scale that provides patients with an overall function score based on a summative score for 3 sub categories (knee function, sports activities, pain/symptoms). A score between 0-100 is obtained as the sum of scores for each individual question, with increasing composite scores correlating positively with patient functional status/quality of life.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Score for the Knee Society Score (KSS) Knee Component at 1 Year Post-operatively</measure>
    <time_frame>12 months post-operatively</time_frame>
    <description>Physician completed Knee Society Score questionnaire used to measure a patient's functional ability before and after total knee arthroplasty (TKA); score range is reported between 0-100 with improvement in outcomes reflected as a higher numerical value (e.g. a 'complete' return to pre-disease functionality would be reported as a score of 100)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Score for the Knee Society Score (KSS) Function Component at 1 Year Post-operatively</measure>
    <time_frame>12 months post-operatively</time_frame>
    <description>Physician completed Knee Society Score questionnaire used to measure a patient's functional ability before and after total knee arthroplasty (TKA); score range is reported between 0-100 with improvement in outcomes reflected as a higher numerical value (e.g. a 'complete' return to pre-disease functionality would be reported as a score of 100)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Assessing Knee Stability Using the KT-1000 Arthrometer (at 30 Degrees)</measure>
    <time_frame>1 year post-operatively</time_frame>
    <description>Used for grading the stability of the knee in various degrees of flexion according to section 4 of the International Knee Documentation Committee's Knee Ligament Standard Evaluation Form where normal (-1 to 2 mm); nearly normal (3 to 5 mm); abnormal (6 to 10 mm); severely abnormal (&gt;10 mm)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessing Knee Stability Using the KT-1000 Arthrometer (at 90 Degrees)</measure>
    <time_frame>1 year post-operatively</time_frame>
    <description>Used for grading the stability of the knee in various degrees of flexion according to section 4 of the International Knee Documentation Committee's Knee Ligament Standard Evaluation Form where normal (-1 to 2 mm); nearly normal (3 to 5 mm); abnormal (6 to 10 mm); severely abnormal (&gt;10 mm)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Get-up-and-Go Test</measure>
    <time_frame>Between 6 months and 1 year post-operatively</time_frame>
    <description>Used to assess a person's mobility and requires both static and dynamic balance. It uses the time that a person takes to rise from a chair, walk three metres, turn around, walk back to the chair, and sit down.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">61</enrollment>
  <condition>Osteoarthritis of Knee</condition>
  <arm_group>
    <arm_group_label>Medacta Sphere</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Ball-and-socket</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Medacta PS</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Cam-and-post</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Medacta GMK posterior stabilized prosthesis</intervention_name>
    <arm_group_label>Medacta PS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Medacta GMK Sphere prosthesis</intervention_name>
    <arm_group_label>Medacta Sphere</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18-85, regardless of gender, ethnicity, or pathology

          -  Must require a total knee arthroplasty

          -  All subjects must have given signed, informed consent prior to registration in study.

        Exclusion Criteria:

          -  Minors

          -  Any patients that are unable to consent

          -  Patients with active infection or osseous tumor of the operative extremity

          -  Patients undergoing revision surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Northwestern Medicine Department of Orthopaedic Surgery</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>October 13, 2015</study_first_submitted>
  <study_first_submitted_qc>October 15, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 16, 2015</study_first_posted>
  <results_first_submitted>March 12, 2019</results_first_submitted>
  <results_first_submitted_qc>May 6, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">May 29, 2019</results_first_posted>
  <last_update_submitted>September 19, 2019</last_update_submitted>
  <last_update_submitted_qc>September 19, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 23, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Northwestern University</investigator_affiliation>
    <investigator_full_name>David W. Manning</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>April 8, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/78/NCT02577978/Prot_SAP_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>March 10, 2015</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/78/NCT02577978/ICF_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Medacta Sphere</title>
          <description>Ball-and-socket
Medacta GMK Sphere prosthesis</description>
        </group>
        <group group_id="P2">
          <title>Medacta PS</title>
          <description>Cam-and-post
Medacta GMK posterior stabilized prosthesis</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="32"/>
                <participants group_id="P2" count="29"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="25"/>
                <participants group_id="P2" count="25"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>From the total 61 patients enrolled, 11 patients (7 sphere, 4 PS) were dropped from the study due to loss to follow-up. The remainder 50 had data collected.</population>
      <group_list>
        <group group_id="B1">
          <title>Medacta Sphere</title>
          <description>Ball-and-socket
Medacta GMK Sphere prosthesis</description>
        </group>
        <group group_id="B2">
          <title>Medacta PS</title>
          <description>Cam-and-post
Medacta GMK posterior stabilized prosthesis</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="25"/>
            <count group_id="B2" value="25"/>
            <count group_id="B3" value="50"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="26"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="67" spread="8"/>
                    <measurement group_id="B2" value="64" spread="7"/>
                    <measurement group_id="B3" value="66" spread="7.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="33"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="22"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body Mass Index (BMI)</title>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="32.8" spread="5.82"/>
                    <measurement group_id="B2" value="34.2" spread="5.81"/>
                    <measurement group_id="B3" value="33.5" spread="5.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Pre-Operative Ambulatory Status</title>
          <description>Patient's ability to ambulate unassisted or assisted with a gait aid</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Unassisted</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cane</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Walker</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Hypertension</title>
          <description>Patients with a medical history significant for hypertension</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Diabetes Mellitus</title>
          <description>Patients with medical history significant for diabetes mellitus</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>History of VTE</title>
          <description>Patients with medical history significant for venous thromboembolism (VTE)</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Pre-operative Narcotic Use</title>
          <description>Patients with recent history of narcotic use for pain management prior to surgery</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Tobacco Use</title>
          <description>Patients with active or recent tobacco use prior to surgery</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Coronary Artery Disease</title>
          <description>Patients with medical history significant for coronary artery disease</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Oxford Knee Score (OKS) Pre-operative Through 2 Years Post-operative</title>
        <description>Patient completed Oxford Knee Score questionnaire used to assess the patient's perspective of outcome following Total Knee Arthroplasty (TKA); score range is reported between 0-48 with improvement in outcomes reflected as a higher numerical value (e.g. a 'complete' return to pre-disease functionality would be reported as a score of 48)</description>
        <time_frame>Pre-operatively on day of surgery, 6 weeks, 3 months, 6 months, 12 months and 24 months post-operatively</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Medacta Sphere</title>
            <description>Ball-and-socket
Medacta GMK Sphere prosthesis</description>
          </group>
          <group group_id="O2">
            <title>Medacta PS</title>
            <description>Cam-and-post
Medacta GMK posterior stabilized prosthesis</description>
          </group>
        </group_list>
        <measure>
          <title>Oxford Knee Score (OKS) Pre-operative Through 2 Years Post-operative</title>
          <description>Patient completed Oxford Knee Score questionnaire used to assess the patient's perspective of outcome following Total Knee Arthroplasty (TKA); score range is reported between 0-48 with improvement in outcomes reflected as a higher numerical value (e.g. a 'complete' return to pre-disease functionality would be reported as a score of 48)</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline Oxford Knee Score</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.31" spread="7.66"/>
                    <measurement group_id="O2" value="19.88" spread="9.39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 wk. Post Op Oxford Knee Score</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="29.96" spread="9.64"/>
                    <measurement group_id="O2" value="28.52" spread="8.77"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 mo. Post Op Oxford Knee Score</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32.0" spread="11.35"/>
                    <measurement group_id="O2" value="32.7" spread="9.47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 mo. Post Op Oxford Knee Score</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33.67" spread="8.9"/>
                    <measurement group_id="O2" value="36.41" spread="10.58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 yr. Post Op Oxford Knee Score</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="39.16" spread="9.97"/>
                    <measurement group_id="O2" value="35.81" spread="11.33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 yr. Post Op Oxford Knee Score</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40.41" spread="8.56"/>
                    <measurement group_id="O2" value="38.28" spread="11.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Veteran's RAND 12 (VR-12) Mental Composite Score (MCS) Through 2 Years Post Operative</title>
        <description>Veteran's RAND 12 Item Health Survey used to assess health-related quality of life, to estimate disease burden, and to evaluate disease-specific benchmarks. Scores for the Mental Composite Score (MCS) range from 5.2 to 76.3 and are evaluated as a summative T-score with population mean of 50 (Standard Deviation = 10);higher scores indicate improved mental wellness/function as reported by patients.</description>
        <time_frame>Pre-operatively, 6 weeks post-operatively, 3 months post-operatively, 6 months post-operatively, 12 months post-operatively, and 2 years post-operatively.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Medacta Sphere</title>
            <description>Ball-and-socket
Medacta GMK Sphere prosthesis</description>
          </group>
          <group group_id="O2">
            <title>Medacta PS</title>
            <description>Cam-and-post
Medacta GMK posterior stabilized prosthesis</description>
          </group>
        </group_list>
        <measure>
          <title>Veteran's RAND 12 (VR-12) Mental Composite Score (MCS) Through 2 Years Post Operative</title>
          <description>Veteran's RAND 12 Item Health Survey used to assess health-related quality of life, to estimate disease burden, and to evaluate disease-specific benchmarks. Scores for the Mental Composite Score (MCS) range from 5.2 to 76.3 and are evaluated as a summative T-score with population mean of 50 (Standard Deviation = 10);higher scores indicate improved mental wellness/function as reported by patients.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline VR-12 MCS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44.97" spread="14.13"/>
                    <measurement group_id="O2" value="54.33" spread="12.35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 wk. VR-12 MCS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="49.25" spread="14.69"/>
                    <measurement group_id="O2" value="59" spread="7.18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 mo. VR-12 MCS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="51.11" spread="11.74"/>
                    <measurement group_id="O2" value="53.71" spread="12.71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 mo. VR-12 MCS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="53.6" spread="11.79"/>
                    <measurement group_id="O2" value="53.85" spread="10.75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 yr. VR-12 MCS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="53.7" spread="11.22"/>
                    <measurement group_id="O2" value="54.09" spread="12.47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 yr. VR-12 MCS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="54.83" spread="9.54"/>
                    <measurement group_id="O2" value="54.78" spread="10.27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Veteran's RAND 12 (VR-12) Physical Composite Score (PCS) Through 2 Years Post Operative</title>
        <description>Veteran's RAND 12 Item Health Survey used to assess health-related quality of life, to estimate disease burden, and to evaluate disease-specific benchmarks. Scores for the Physical Composite Score (MCS) range from 6.3 to 71.8 and are evaluated as a summative T-score with population mean of 50 (Standard Deviation = 10);higher scores indicate improved physical wellness/function as reported by patients.</description>
        <time_frame>Pre-operatively, 6 weeks post-operatively, 3 months post-operatively, 6 months post-operatively, 12 months post-operatively, and 2 years post-operatively.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Medacta Sphere</title>
            <description>Ball-and-socket
Medacta GMK Sphere prosthesis</description>
          </group>
          <group group_id="O2">
            <title>Medacta PS</title>
            <description>Cam-and-post
Medacta GMK posterior stabilized prosthesis</description>
          </group>
        </group_list>
        <measure>
          <title>Veteran's RAND 12 (VR-12) Physical Composite Score (PCS) Through 2 Years Post Operative</title>
          <description>Veteran's RAND 12 Item Health Survey used to assess health-related quality of life, to estimate disease burden, and to evaluate disease-specific benchmarks. Scores for the Physical Composite Score (MCS) range from 6.3 to 71.8 and are evaluated as a summative T-score with population mean of 50 (Standard Deviation = 10);higher scores indicate improved physical wellness/function as reported by patients.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline VR-12 PCS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26.74" spread="8.3"/>
                    <measurement group_id="O2" value="23.92" spread="6.71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 wk. VR-12 PCS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34.5" spread="8.1"/>
                    <measurement group_id="O2" value="34.02" spread="11.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 mo. VR-12 PCS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38.27" spread="12.58"/>
                    <measurement group_id="O2" value="35.9" spread="10.28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 mo. VR-12 PCS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="39.5" spread="10.23"/>
                    <measurement group_id="O2" value="42.1" spread="11.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 yr. VR-12 PCS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="46.36" spread="12.22"/>
                    <measurement group_id="O2" value="42.48" spread="12.54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 yr. VR-12 PCS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42.76" spread="11.08"/>
                    <measurement group_id="O2" value="46.01" spread="12.85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>PROMIS Computerized Adaptive Tests (CATs) for Physical Function Through 2 Years Post-operative</title>
        <description>Patient-reported outcome (PRO) measures use answers that patients provide to questions to produce numeric values which indicate patients' state of wellbeing or suffering as well as their ability or lack of ability to function. Values are reported as T-scores with a reference population mean of 50 (SD=10); for the Physical Function domain higher scores indicated improved physical function as reported by the patient</description>
        <time_frame>Pre-operatively, 6 weeks post-operatively, 3 months post-operatively, 6 months post-operatively, 12 months post-operatively, and 2 years post-operatively.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Medacta Sphere</title>
            <description>Ball-and-socket
Medacta GMK Sphere prosthesis</description>
          </group>
          <group group_id="O2">
            <title>Medacta PS</title>
            <description>Cam-and-post
Medacta GMK posterior stabilized prosthesis</description>
          </group>
        </group_list>
        <measure>
          <title>PROMIS Computerized Adaptive Tests (CATs) for Physical Function Through 2 Years Post-operative</title>
          <description>Patient-reported outcome (PRO) measures use answers that patients provide to questions to produce numeric values which indicate patients' state of wellbeing or suffering as well as their ability or lack of ability to function. Values are reported as T-scores with a reference population mean of 50 (SD=10); for the Physical Function domain higher scores indicated improved physical function as reported by the patient</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline PROMIS Physical Function</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32.92" spread="4.44"/>
                    <measurement group_id="O2" value="31.24" spread="5.27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 wk. PROMIS Physical Function</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38.38" spread="6.95"/>
                    <measurement group_id="O2" value="39.96" spread="6.45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 mo. PROMIS Physical Function</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42.12" spread="8.14"/>
                    <measurement group_id="O2" value="41.32" spread="6.76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 mo. PROMIS Physical Function</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="43.81" spread="7.26"/>
                    <measurement group_id="O2" value="45.36" spread="9.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 yr. PROMIS Physical Function</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="48.06" spread="9.22"/>
                    <measurement group_id="O2" value="48.9" spread="10.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 yr. PROMIS Physical Function</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="49.17" spread="7.84"/>
                    <measurement group_id="O2" value="46.5" spread="8.97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>PROMIS Computerized Adaptive Tests (CATs) for Pain Interference Through 2 Years Post-operative</title>
        <description>Patient-reported outcome (PRO) measures use answers that patients provide to questions to produce numeric values which indicate patients' state of wellbeing or suffering as well as their ability or lack of ability to function. Values are reported as T-scores with a reference population mean of 50 (SD=10); for the Pain Interference domain an increased value indicates greater severity/frequency of pain reported by the patient.</description>
        <time_frame>Pre-operatively, 6 weeks post-operatively, 3 months post-operatively, 6 months post-operatively, 12 months post-operatively, and 2 years post-operatively.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Medacta Sphere</title>
            <description>Ball-and-socket
Medacta GMK Sphere prosthesis</description>
          </group>
          <group group_id="O2">
            <title>Medacta PS</title>
            <description>Cam-and-post
Medacta GMK posterior stabilized prosthesis</description>
          </group>
        </group_list>
        <measure>
          <title>PROMIS Computerized Adaptive Tests (CATs) for Pain Interference Through 2 Years Post-operative</title>
          <description>Patient-reported outcome (PRO) measures use answers that patients provide to questions to produce numeric values which indicate patients' state of wellbeing or suffering as well as their ability or lack of ability to function. Values are reported as T-scores with a reference population mean of 50 (SD=10); for the Pain Interference domain an increased value indicates greater severity/frequency of pain reported by the patient.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline PROMIS Pain Interference</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="66.03" spread="4.73"/>
                    <measurement group_id="O2" value="65.88" spread="7.39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 wk. PROMIS Pain Interference</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="58.23" spread="8.59"/>
                    <measurement group_id="O2" value="58.2" spread="7.62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 mo. PROMIS Pain Interference</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="55.9" spread="11.48"/>
                    <measurement group_id="O2" value="55.53" spread="9.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 mo. PROMIS Pain Interference</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="52.83" spread="9.31"/>
                    <measurement group_id="O2" value="53.27" spread="12.35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 yr. PROMIS Pain Interference</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="46.65" spread="11.22"/>
                    <measurement group_id="O2" value="49.98" spread="11.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 yr. PROMIS Pain Interference</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44.7" spread="8.63"/>
                    <measurement group_id="O2" value="46.97" spread="10.96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>PROMIS Computerized Adaptive Tests (CATs) for Pain Behavior Through 2 Years Post-operative</title>
        <description>Patient-reported outcome (PRO) measures use answers that patients provide to questions to produce numeric values which indicate patients' state of wellbeing or suffering as well as their ability or lack of ability to function. Values are reported as T-scores with a reference population mean of 50 (SD=10); for the Pain Behavior domain an increased value indicates greater severity/frequency of pain reported by the patient</description>
        <time_frame>Pre-operatively, 6 weeks post-operatively, 3 months post-operatively, 6 months post-operatively, 12 months post-operatively, and 2 years post-operatively.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Medacta Sphere</title>
            <description>Ball-and-socket
Medacta GMK Sphere prosthesis</description>
          </group>
          <group group_id="O2">
            <title>Medacta PS</title>
            <description>Cam-and-post
Medacta GMK posterior stabilized prosthesis</description>
          </group>
        </group_list>
        <measure>
          <title>PROMIS Computerized Adaptive Tests (CATs) for Pain Behavior Through 2 Years Post-operative</title>
          <description>Patient-reported outcome (PRO) measures use answers that patients provide to questions to produce numeric values which indicate patients' state of wellbeing or suffering as well as their ability or lack of ability to function. Values are reported as T-scores with a reference population mean of 50 (SD=10); for the Pain Behavior domain an increased value indicates greater severity/frequency of pain reported by the patient</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline PROMIS Pain Behavior</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="60.98" spread="3.22"/>
                    <measurement group_id="O2" value="60.92" spread="4.88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 wk. PROMIS Pain Behavior</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="56.79" spread="7.27"/>
                    <measurement group_id="O2" value="58.49" spread="3.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 mo. PROMIS Pain Behavior</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="54.14" spread="7.78"/>
                    <measurement group_id="O2" value="53.6" spread="9.41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 mo. PROMIS Pain Behavior</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="53.2" spread="8.72"/>
                    <measurement group_id="O2" value="51.25" spread="9.27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 yr. PROMIS Pain Behavior</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="45.92" spread="11.31"/>
                    <measurement group_id="O2" value="47.95" spread="12.43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 yr. PROMIS Pain Behavior</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42.76" spread="9.09"/>
                    <measurement group_id="O2" value="46.29" spread="10.36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Total Score Calculated Using the Forgotten Joint Score in Order to Assess the Subject's Ability to Forget the Artificial Joint in Everyday Life</title>
        <description>Patient completed questionnaire used to assess the patients' ability to forget about a joint as a result of successful treatment. Every question is scored 1 (never) to 5 (mostly) according to the selected response categories. Thus, the raw score ranges from 12 to 60 where a high score indicates an improved outcome. The raw score is linearly transformed to a 0-100 scale and then reversed to obtain the final score with higher scores indicating improved physical function/reduced impact of symptoms on activity:
Final score = 100 - ((sum(item01 to item12) - 12)/48*100)</description>
        <time_frame>12 months post-operatively</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Medacta Sphere</title>
            <description>Ball-and-socket
Medacta GMK Sphere prosthesis</description>
          </group>
          <group group_id="O2">
            <title>Medacta PS</title>
            <description>Cam-and-post
Medacta GMK posterior stabilized prosthesis</description>
          </group>
        </group_list>
        <measure>
          <title>Total Score Calculated Using the Forgotten Joint Score in Order to Assess the Subject's Ability to Forget the Artificial Joint in Everyday Life</title>
          <description>Patient completed questionnaire used to assess the patients' ability to forget about a joint as a result of successful treatment. Every question is scored 1 (never) to 5 (mostly) according to the selected response categories. Thus, the raw score ranges from 12 to 60 where a high score indicates an improved outcome. The raw score is linearly transformed to a 0-100 scale and then reversed to obtain the final score with higher scores indicating improved physical function/reduced impact of symptoms on activity:
Final score = 100 - ((sum(item01 to item12) - 12)/48*100)</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="57.1" spread="37.6"/>
                    <measurement group_id="O2" value="54.6" spread="41.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>International Knee Documentation Committee (IKDC) Questionnaire Assessed Through 2 Years Post-op</title>
        <description>The International Knee Documentation Committe (IKDC) Questionnaire is a subjective scale that provides patients with an overall function score based on a summative score for 3 sub categories (knee function, sports activities, pain/symptoms). A score between 0-100 is obtained as the sum of scores for each individual question, with increasing composite scores correlating positively with patient functional status/quality of life.</description>
        <time_frame>Pre-operatively, 6 weeks post-operatively, 3 months post-operatively, 6 months post-operatively, 12 months post-operatively, and 2 years post-operatively.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Medacta Sphere</title>
            <description>Ball-and-socket
Medacta GMK Sphere prosthesis</description>
          </group>
          <group group_id="O2">
            <title>Medacta PS</title>
            <description>Cam-and-post
Medacta GMK posterior stabilized prosthesis</description>
          </group>
        </group_list>
        <measure>
          <title>International Knee Documentation Committee (IKDC) Questionnaire Assessed Through 2 Years Post-op</title>
          <description>The International Knee Documentation Committe (IKDC) Questionnaire is a subjective scale that provides patients with an overall function score based on a summative score for 3 sub categories (knee function, sports activities, pain/symptoms). A score between 0-100 is obtained as the sum of scores for each individual question, with increasing composite scores correlating positively with patient functional status/quality of life.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline IKDC Composite</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35.82" spread="8.72"/>
                    <measurement group_id="O2" value="35.97" spread="6.97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 wk. IKDC Composite</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42.38" spread="11.19"/>
                    <measurement group_id="O2" value="43.91" spread="7.68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 mo. IKDC Composite</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50.41" spread="11.44"/>
                    <measurement group_id="O2" value="44.5" spread="10.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 mo. IKDC Composite</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="48.72" spread="12.08"/>
                    <measurement group_id="O2" value="48.52" spread="11.73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 yr. IKDC Composite</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="57.97" spread="13.79"/>
                    <measurement group_id="O2" value="52.66" spread="13.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 yr. IKDC Composite</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="51.26" spread="8.67"/>
                    <measurement group_id="O2" value="49.3" spread="10.56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Score for the Knee Society Score (KSS) Knee Component at 1 Year Post-operatively</title>
        <description>Physician completed Knee Society Score questionnaire used to measure a patient's functional ability before and after total knee arthroplasty (TKA); score range is reported between 0-100 with improvement in outcomes reflected as a higher numerical value (e.g. a 'complete' return to pre-disease functionality would be reported as a score of 100)</description>
        <time_frame>12 months post-operatively</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Medacta Sphere</title>
            <description>Ball-and-socket
Medacta GMK Sphere prosthesis</description>
          </group>
          <group group_id="O2">
            <title>Medacta PS</title>
            <description>Cam-and-post
Medacta GMK posterior stabilized prosthesis</description>
          </group>
        </group_list>
        <measure>
          <title>Score for the Knee Society Score (KSS) Knee Component at 1 Year Post-operatively</title>
          <description>Physician completed Knee Society Score questionnaire used to measure a patient's functional ability before and after total knee arthroplasty (TKA); score range is reported between 0-100 with improvement in outcomes reflected as a higher numerical value (e.g. a 'complete' return to pre-disease functionality would be reported as a score of 100)</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="88.1" spread="9.5"/>
                    <measurement group_id="O2" value="86.0" spread="12.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Score for the Knee Society Score (KSS) Function Component at 1 Year Post-operatively</title>
        <description>Physician completed Knee Society Score questionnaire used to measure a patient's functional ability before and after total knee arthroplasty (TKA); score range is reported between 0-100 with improvement in outcomes reflected as a higher numerical value (e.g. a 'complete' return to pre-disease functionality would be reported as a score of 100)</description>
        <time_frame>12 months post-operatively</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Medacta Sphere</title>
            <description>Ball-and-socket
Medacta GMK Sphere prosthesis</description>
          </group>
          <group group_id="O2">
            <title>Medacta PS</title>
            <description>Cam-and-post
Medacta GMK posterior stabilized prosthesis</description>
          </group>
        </group_list>
        <measure>
          <title>Score for the Knee Society Score (KSS) Function Component at 1 Year Post-operatively</title>
          <description>Physician completed Knee Society Score questionnaire used to measure a patient's functional ability before and after total knee arthroplasty (TKA); score range is reported between 0-100 with improvement in outcomes reflected as a higher numerical value (e.g. a 'complete' return to pre-disease functionality would be reported as a score of 100)</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="81.4" spread="17.9"/>
                    <measurement group_id="O2" value="77.4" spread="22.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Assessing Knee Stability Using the KT-1000 Arthrometer (at 30 Degrees)</title>
        <description>Used for grading the stability of the knee in various degrees of flexion according to section 4 of the International Knee Documentation Committee's Knee Ligament Standard Evaluation Form where normal (-1 to 2 mm); nearly normal (3 to 5 mm); abnormal (6 to 10 mm); severely abnormal (&gt;10 mm)</description>
        <time_frame>1 year post-operatively</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Medacta Sphere</title>
            <description>Ball-and-socket
Medacta GMK Sphere prosthesis</description>
          </group>
          <group group_id="O2">
            <title>Medacta PS</title>
            <description>Cam-and-post
Medacta GMK posterior stabilized prosthesis</description>
          </group>
        </group_list>
        <measure>
          <title>Assessing Knee Stability Using the KT-1000 Arthrometer (at 30 Degrees)</title>
          <description>Used for grading the stability of the knee in various degrees of flexion according to section 4 of the International Knee Documentation Committee's Knee Ligament Standard Evaluation Form where normal (-1 to 2 mm); nearly normal (3 to 5 mm); abnormal (6 to 10 mm); severely abnormal (&gt;10 mm)</description>
          <units>millimeters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.6" spread="1.9"/>
                    <measurement group_id="O2" value="10.2" spread="2.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Assessing Knee Stability Using the KT-1000 Arthrometer (at 90 Degrees)</title>
        <description>Used for grading the stability of the knee in various degrees of flexion according to section 4 of the International Knee Documentation Committee's Knee Ligament Standard Evaluation Form where normal (-1 to 2 mm); nearly normal (3 to 5 mm); abnormal (6 to 10 mm); severely abnormal (&gt;10 mm)</description>
        <time_frame>1 year post-operatively</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Medacta Sphere</title>
            <description>Ball-and-socket
Medacta GMK Sphere prosthesis</description>
          </group>
          <group group_id="O2">
            <title>Medacta PS</title>
            <description>Cam-and-post
Medacta GMK posterior stabilized prosthesis</description>
          </group>
        </group_list>
        <measure>
          <title>Assessing Knee Stability Using the KT-1000 Arthrometer (at 90 Degrees)</title>
          <description>Used for grading the stability of the knee in various degrees of flexion according to section 4 of the International Knee Documentation Committee's Knee Ligament Standard Evaluation Form where normal (-1 to 2 mm); nearly normal (3 to 5 mm); abnormal (6 to 10 mm); severely abnormal (&gt;10 mm)</description>
          <units>millimeters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.1" spread="2.0"/>
                    <measurement group_id="O2" value="5.6" spread="1.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Get-up-and-Go Test</title>
        <description>Used to assess a person's mobility and requires both static and dynamic balance. It uses the time that a person takes to rise from a chair, walk three metres, turn around, walk back to the chair, and sit down.</description>
        <time_frame>Between 6 months and 1 year post-operatively</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Medacta Sphere</title>
            <description>Ball-and-socket
Medacta GMK Sphere prosthesis</description>
          </group>
          <group group_id="O2">
            <title>Medacta PS</title>
            <description>Cam-and-post
Medacta GMK posterior stabilized prosthesis</description>
          </group>
        </group_list>
        <measure>
          <title>Get-up-and-Go Test</title>
          <description>Used to assess a person's mobility and requires both static and dynamic balance. It uses the time that a person takes to rise from a chair, walk three metres, turn around, walk back to the chair, and sit down.</description>
          <units>seconds</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.2" spread="3.7"/>
                    <measurement group_id="O2" value="10.5" spread="5.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <desc>All-Cause Mortality, Serious, and Other (Not Including Serious) Adverse Events were not monitored/assessed</desc>
      <group_list>
        <group group_id="E1">
          <title>Medacta Sphere</title>
          <description>Ball-and-socket
Medacta GMK Sphere prosthesis</description>
        </group>
        <group group_id="E2">
          <title>Medacta PS</title>
          <description>Cam-and-post
Medacta GMK posterior stabilized prosthesis</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>David W Manning</name_or_title>
      <organization>Northwestern Medicine</organization>
      <phone>3124726023</phone>
      <email>David.Manning@nm.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

